131 related articles for article (PubMed ID: 30374620)
1. ELMO3 - a Negative Prognostic Marker in Minor Salivary Gland Carcinoma.
Kotowski U; Kadletz L; Schneider S; Oberndorfer F; Erovic BM; Grasl MC; Lill C; Heiduschka G
Pathol Oncol Res; 2019 Apr; 25(2):585-591. PubMed ID: 30374620
[TBL] [Abstract][Full Text] [Related]
2. ELMO3 expression indicates a poor prognosis in head and neck squamous cell carcinoma - a short report.
Kadletz L; Heiduschka G; Wiebringhaus R; Gurnhofer E; Kotowski U; Haymerle G; Brunner M; Barry C; Kenner L
Cell Oncol (Dordr); 2017 Apr; 40(2):193-198. PubMed ID: 28039609
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of DCLK1 is predictive for recurrent disease in major salivary gland malignancies.
Kadletz L; Aumayr K; Heiduschka G; Schneider S; Enzenhofer E; Lill C
Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):467-475. PubMed ID: 27470117
[TBL] [Abstract][Full Text] [Related]
4. Minor salivary gland carcinoma: a review of 35 cases.
Haymerle G; Schneider S; Harris L; Häupl T; Schopper C; Pammer J; Grasl MCh; Erovic BM
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2717-26. PubMed ID: 26498950
[TBL] [Abstract][Full Text] [Related]
5. ELMO3 predicts poor outcome in T1 laryngeal cancer.
Haymerle G; Kadletz L; Wiebringhaus R; Golabi B; Mildner M; Thurnher D; Heiduschka G
Clin Otolaryngol; 2017 Dec; 42(6):1181-1186. PubMed ID: 28166396
[TBL] [Abstract][Full Text] [Related]
6. ELMO3 is a novel biomarker for diagnosis and prognosis of non-small cell lung cancer.
Fan W; Yang H; Xue H; Sun Y; Zhang J
Int J Clin Exp Pathol; 2015; 8(5):5503-8. PubMed ID: 26191257
[TBL] [Abstract][Full Text] [Related]
7. Silencing ELMO3 Inhibits the Growth, Invasion, and Metastasis of Gastric Cancer.
Hu Y; Yu Q; Zhong Y; Shen W; Zhou X; Liu X; Xu M; Zhou N; Min W; Gao D
Biomed Res Int; 2018; 2018():3764032. PubMed ID: 30345300
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of β-catenin, cyclin D1 and PIN1 in minor salivary gland carcinoma: β-catenin predicts overall survival.
Schneider S; Thurnher D; Seemann R; Brunner M; Kadletz L; Ghanim B; Aumayr K; Heiduschka G; Lill C
Eur Arch Otorhinolaryngol; 2016 May; 273(5):1283-92. PubMed ID: 25801951
[TBL] [Abstract][Full Text] [Related]
9. Ataxia-Telangiectasia-Mutated Protein Expression as a Prognostic Marker in Adenoid Cystic Carcinoma of the Salivary Glands.
Bazarsad S; Kim JY; Zhang X; Kim KY; Lee DY; Ryu MH; Kim J
Yonsei Med J; 2018 Aug; 59(6):717-726. PubMed ID: 29978608
[TBL] [Abstract][Full Text] [Related]
10. Concomitant expression of ezrin and HER2 predicts distant metastasis and poor prognosis of patients with salivary gland carcinomas.
Hashimoto K; Hayashi R; Mukaigawa T; Yamazaki M; Fujii S
Hum Pathol; 2017 May; 63():110-119. PubMed ID: 28300573
[TBL] [Abstract][Full Text] [Related]
11. High expression level of geminin predicts a poor clinical outcome in salivary gland carcinomas.
Yamazaki M; Fujii S; Murata Y; Hayashi R; Ochiai A
Histopathology; 2010 Jun; 56(7):883-92. PubMed ID: 20497246
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of p27 and Ki-67 expression in mucoepidermoid carcinoma of the intraoral minor salivary gland.
Okabe M; Inagaki H; Murase T; Inoue M; Nagai N; Eimoto T
Mod Pathol; 2001 Oct; 14(10):1008-14. PubMed ID: 11598171
[TBL] [Abstract][Full Text] [Related]
13. Stage as major long term outcome predictor in minor salivary gland carcinoma.
Vander Poorten VL; Balm AJ; Hilgers FJ; Tan IB; Keus RB; Hart AA
Cancer; 2000 Sep; 89(6):1195-204. PubMed ID: 11002213
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression profiles of mucin antigens in salivary gland mucoepidermoid carcinoma: MUC4- and MUC6-negative expression predicts a shortened survival in the early postoperative phase.
Honjo K; Hiraki T; Higashi M; Noguchi H; Nomoto M; Yoshimura T; Batra SK; Yonezawa S; Semba I; Nakamura N; Tanimoto A; Yamada S
Histol Histopathol; 2018 Feb; 33(2):201-213. PubMed ID: 28649694
[TBL] [Abstract][Full Text] [Related]
15. Early stage minor salivary gland adenoid cystic carcinoma has favourable prognosis.
Hämetoja H; Hirvonen K; Hagström J; Leivo I; Saarilahti K; Apajalahti S; Haglund C; Mäkitie A; Bäck L
Virchows Arch; 2017 Dec; 471(6):785-792. PubMed ID: 28600602
[TBL] [Abstract][Full Text] [Related]
16. Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE-A and NY-ESO-1 expression in adenoid cystic carcinoma.
Beppu S; Ito Y; Fujii K; Saida K; Takino H; Masaki A; Murase T; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Ijichi K; Murakami S; Inagaki H
Histopathology; 2017 Aug; 71(2):305-315. PubMed ID: 28370175
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in patients with minor salivary gland carcinoma of the oral cavity and oropharynx.
Carrillo JF; Maldonado F; Carrillo LC; Ramirez-Ortega MC; Pizano JG; Melo C; Chanona JG; Luna-Ortiz K; Ocaña LF
Head Neck; 2011 Oct; 33(10):1406-12. PubMed ID: 21928413
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of RB1-inducible coiled-coil 1 in salivary gland cancers.
Tameno H; Chano T; Ikebuchi K; Ochi Y; Arai A; Kishimoto M; Shimada T; Hisa Y; Okabe H
Head Neck; 2012 May; 34(5):674-80. PubMed ID: 21717524
[TBL] [Abstract][Full Text] [Related]
19. Multimodal treatment of patients with minor salivary gland cancer in the case of recurrent disease.
Erovic BM; Schopper C; Pammer J; Vormittag L; Maleki A; Brunner M; Heiduschka G; Grasl MCh; Thurnher D
Head Neck; 2010 Sep; 32(9):1167-72. PubMed ID: 20191625
[TBL] [Abstract][Full Text] [Related]
20. [Effectiveness evaluation and prognostic factor analysis in patients with minor salivary gland carcinoma of the hard palate].
Liu XK; Zeng ZY; Chen FJ; Guo ZM; Xu GP; Yang AK; Zhang Q
Ai Zheng; 2003 Oct; 22(10):1088-92. PubMed ID: 14558958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
